Press Releases

MAKING THE PRESS

Mary Crowley Cancer Research welcomes new Chief Executive Officer, Jon Friedenberg

Mary Crowley Cancer Research welcomes new Chief Executive Officer, Jon Friedenberg

Jon Friedenberg brings a wealth of experience in healthcare leadership to his new appointment as Chief Executive Officer at Mary Crowley Cancer Research.

Expanding Therapies for Prostate Cancer

Expanding Therapies for Prostate Cancer

The prostate is a hormonally regulated organ and prostate cancer is reliant on androgen receptor signaling for growth. The treatment of advanced prostate cancer has thus traditionally focused on the inhibition of androgen signaling (for example through blockade of the androgen receptor, or inhibition of testosterone production). In the majority of cases, however, the prostate cancer will adapt to low androgen states and become castrate-resistant.

COVID-19 Precautions

COVID-19 Precautions

A message from our Chairman of the Board Roy Lamkin.

Runway for Hope: Lynn Lentscher's Speech

Runway for Hope: Lynn Lentscher's Speech

The Be the Difference Foundation presented Runway for Hope, a luncheon and fashion show benefiting Mary Crowley Cancer Research on September 26th. This speech was given by Be the Difference co-founder, Runway for Hope co-chair, and ovarian cancer survivor Lynn Lentscher. 

Be the Difference Foundation Announces Runway for Hope: A Luncheon and Fashion Show Benefiting Mary Crowley Cancer Research

Be the Difference Foundation Announces Runway for Hope: A Luncheon and Fashion Show Benefiting Mary Crowley Cancer Research

Join Be the Difference Foundation for their inaugural luncheon and fashion show, Runway for Hope, benefitting Mary Crowley Cancer Research, Thursday, September 26, 2019, from 11:30 AM to 1:30 PM at Arlington Hall, 3333 Turtle Creek Boulevard, Dallas, TX 75219.

Celebrating 20 Years